190 related articles for article (PubMed ID: 25701464)
1. CUGBP1 promotes cell proliferation and suppresses apoptosis via down-regulating C/EBPα in human non-small cell lung cancers.
Lu H; Yu Z; Liu S; Cui L; Chen X; Yao R
Med Oncol; 2015 Mar; 32(3):82. PubMed ID: 25701464
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of CUGBP1 is associated with the progression of non-small cell lung cancer.
Gao C; Yu Z; Liu S; Xin H; Li X
Tumour Biol; 2015 Jun; 36(6):4583-9. PubMed ID: 25619475
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2.
Lin PC; Huang HD; Chang CC; Chang YS; Yen JC; Lee CC; Chang WH; Liu TC; Chang JG
BMC Cancer; 2016 Aug; 16():583. PubMed ID: 27485439
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation and antiproliferative role of C/EBPalpha in lung cancer.
Halmos B; Huettner CS; Kocher O; Ferenczi K; Karp DD; Tenen DG
Cancer Res; 2002 Jan; 62(2):528-34. PubMed ID: 11809705
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of CUG-binding protein 1 expression and vascular invasion after radical surgery for stage IB nonsmall cell lung cancer.
Zhao J; Zhao Y; Xuan Y; Jiao W; Qiu T; Wang Z; Luo Y
Indian J Cancer; 2015 Dec; 52 Suppl 2():e125-9. PubMed ID: 26728670
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of C/EBPalpha in non-small cell lung cancer reveals frequent down-regulation in stage II and IIIA tumors: a correlative study of E3590.
Costa DB; Li S; Kocher O; Feins RH; Keller SM; Schiller JH; Johnson DH; Tenen DG; Halmos B
Lung Cancer; 2007 Apr; 56(1):97-103. PubMed ID: 17239984
[TBL] [Abstract][Full Text] [Related]
7. C/EBPα Suppresses Lung Adenocarcinoma Cell Invasion and Migration by Inhibiting β-Catenin.
Lu J; Du C; Yao J; Wu B; Duan Y; Zhou L; Xu D; Zhou F; Gu L; Zhou H; Sun Y
Cell Physiol Biochem; 2017; 42(5):1779-1788. PubMed ID: 28746919
[TBL] [Abstract][Full Text] [Related]
8. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer.
Shi X; Sun M; Liu H; Yao Y; Kong R; Chen F; Song Y
Mol Carcinog; 2015 Jun; 54 Suppl 1():E1-E12. PubMed ID: 24357161
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
10. CCAAT/enhancer-binding protein-α suppresses lung tumor development in mice through the p38α MAP kinase pathway.
Sato A; Yamada N; Ogawa Y; Ikegami M
PLoS One; 2013; 8(2):e57013. PubMed ID: 23437297
[TBL] [Abstract][Full Text] [Related]
11. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of TRIB2 in human lung cancers contributes to tumorigenesis through downregulation of C/EBPα.
Grandinetti KB; Stevens TA; Ha S; Salamone RJ; Walker JR; Zhang J; Agarwalla S; Tenen DG; Peters EC; Reddy VA
Oncogene; 2011 Jul; 30(30):3328-35. PubMed ID: 21399661
[TBL] [Abstract][Full Text] [Related]
13. miR-205 regulates A549 cells proliferation by targeting PTEN.
Bai J; Zhu X; Ma J; Wang W
Int J Clin Exp Pathol; 2015; 8(2):1175-83. PubMed ID: 25973003
[TBL] [Abstract][Full Text] [Related]
14. A novel pathway in NSCLC cells: miR‑191, targeting NFIA, is induced by chronic hypoxia, and promotes cell proliferation and migration.
Zhao J; Qiao CR; Ding Z; Sheng YL; Li XN; Yang Y; Zhu DY; Zhang CY; Liu DL; Wu K; Zhao S
Mol Med Rep; 2017 Mar; 15(3):1319-1325. PubMed ID: 28075452
[TBL] [Abstract][Full Text] [Related]
15. microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.
Huang J; Sun C; Wang S; He Q; Li D
Mol Biosyst; 2015 Jul; 11(7):2051-9. PubMed ID: 25988292
[TBL] [Abstract][Full Text] [Related]
16. Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.
Cai F; Zhu Q; Miao Y; Shen S; Su X; Shi Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):59-69. PubMed ID: 27629878
[TBL] [Abstract][Full Text] [Related]
17. HDAC1 cooperates with C/EBPalpha in the inhibition of liver proliferation in old mice.
Wang GL; Salisbury E; Shi X; Timchenko L; Medrano EE; Timchenko NA
J Biol Chem; 2008 Sep; 283(38):26169-78. PubMed ID: 18622015
[TBL] [Abstract][Full Text] [Related]
18. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.
Lv L; Wan C; Chen B; Li M; Liu Y; Ni T; Yang Y; Liu Y; Cong X; Mao G; Xue Q
J Cell Biochem; 2014 Jan; 115(1):81-92. PubMed ID: 23904219
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia regulates the expression and localization of CCAAT/enhancer binding protein α by hypoxia inducible factor-1α in bladder transitional carcinoma cells.
Xue M; Li X; Chen W
Mol Med Rep; 2015 Aug; 12(2):2121-7. PubMed ID: 25824695
[TBL] [Abstract][Full Text] [Related]
20. miR-1238 inhibits cell proliferation by targeting LHX2 in non-small cell lung cancer.
Shi X; Zhan L; Xiao C; Lei Z; Yang H; Wang L; Zhao J; Zhang HT
Oncotarget; 2015 Aug; 6(22):19043-54. PubMed ID: 26189214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]